Aquaporin-4 antibodies (AQP4-Ab) are associated with neuromyelitis optica spectrum disorder (NMOSD) and typically this disorder has a poor visual prognosis as a result of optic neuritis (ON). Our aim was to report the clinical features at onset and final visual outcomes at 6 months of patients with ON who were positive for AQP4-Ab vs. those who were negative for AQP4-Ab.
Want to read more?
Log in or sign up to access all Neurodiem content.
Already have an account? Log In
All rights reserved. © 2019 Health Learning, Research & Practice, a business of Wolters Kluwer Health/ North American Neuro-Ophthalmology Society and its affiliates take no responsibility for the accuracy of the Local Edition from the published English original and are not liable for any errors which may occur.